Hard to heal pressure ulcers (stage III-IV): Efficacy of injected activated macrophage suspension (AMS) as compared with standard of care (SOC) treatment controlled trial

Archives of Gerontology and Geriatrics

Volumn 51, Issue 3, 2010, Pages 268-272

  Zuloff Shani, Adi ^a,b   Adunsky, Abraham ^b   Even Zahav, Aviva ^b   Semo, Haim ^b   Orenstein, Arie ^b   Tamir, Jeremy ^b   Regev, Eli ^b   Shinar, Eilat ^a   Danon, David ^a  

^a MAGEN DAVID ADOM   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Activated macrophage suspension; Pressure ulcers; Wound healing in elderly

Indexed keywords

ACTIVATED MACROPHAGE SUSPENSION; UNCLASSIFIED DRUG; WOUND HEALING PROMOTING AGENT;

AGED; ARTICLE; CELL THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; DECUBITUS; DIABETIC FOOT; DIABETIC PATIENT; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOOT ULCER; HEAL PRESSURE ULCER; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEG ULCER; LOCAL THERAPY; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT RESPONSE; WOUND HEALING;

AGED; FEMALE; HUMANS; MACROPHAGES; MALE; PRESSURE ULCER; PROSPECTIVE STUDIES; SUSPENSIONS; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING;

EID: 77957334356     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2009.11.015     Document Type: Article

References (16)

1. Bennett G., Dealey C., Posnett J. The cost of pressure ulcers in the UK. Age Ageing 2004, 33:230-235.
2. Brandeis G.H., Morris J.N., Nash D.J., Lipsitz L.A. The epidemiology and natural history of pressure ulcers in elderly nursing home resident. J. Am. Med. Assoc. 1990, 264:2905-2909.
3. Brem H., Balledux J., Bloom T., Kerstein M.D., Hollier L. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing. Arch. Surg. 2000, 135:627-634.
4. Cuddigan J., Frantz R.A. Pressure ulcer research: pressure ulcer treatment. A monograph from the National Pressure Ulcer Advisory Panel. Adv. Wound Care 1998, 11:294-300.
5. Danon D., Madjar J., Edinov E., Knyszynski A., Brill S., Diamantshtein L., Shinar E. Treatment of human ulcers by application of macrophages prepared from blood unit. Exp. Gerontol. 1997, 32:633-641.
6. Diegelmann R.F., Evans M.C. Wound healing: an overview of acute, fibrotic and delayed healing. Front. Biosci. 2004, 9:283-289.
7. Javitz H.S., Ward M.M., Martens L. Major costs associated with pressure sores. J. Wound Care 1998, 7:286-290.
8. Jacquot J.M., Pelissier J., Finels H., Strubel D. Epidemiology and cost of pressure sores in the aged. Presse Med. 1999, 28:1854-1860.
9. Landi F., Aloe L., Russo A., Cesari M., Onder G., Bonini S., Carbonin P., Bernabei U.R. Topical treatment of pressure ulcers with nerve growth factor: a randomized clinical trial. Ann. Intern. Med. 2003, 139:635-641.
10. Leibovich S.J., Danon D. Promotion of wound repair in mice by application of glucan. J. Reticuloendothel. Soc. 1980, 27:1-11.
11. Mosser D.M. The many faces of macrophage activation. J. Leukoc. Biol. 2003, 73:209-212.
12. Norton D., McLaren R., Exton-Smith A.N. An Investigation of Geriatric Nursing Problems in the Hospital 1962, National Corporation for the Care of Old People (now the Centre for Policy on Ageing) Treatment, London.
13. Reddy M., Gill S.S., Kalkar S.R., Wu W., Anderson P.J., Rochon P.A. Treatment of pressure ulcers: a systematic review. J. Am. Med. Assoc. 2008, 300:2647-2662.
14. Rees R.S., Robson M.C., Smiell J.M., Perry B.H. Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study. Wound Repair Regen. 1999, 7:141-147.
15. Stout R.D., Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 2004, 76:509-513.
16. Stout R.D., Suttles J. Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes. Immunol. Rev. 2005, 205:60-71.